Search for content, post, videos

Per Norlén is the new CEO of Evaxion

Per Norlen Photo Jenny Leyman
Evaxion Biotech has announced that its new Chief Executive Officer (CEO) Per Norlén has joined the company on October 3rd. “With Per at the steering wheel, we expect to bring our promising clinical and preclinical results to the next level. Evaxion is a profoundly innovative and talented compa
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.